Axelsen Mads B.

Biography

Mads Buhl Axelsen joined Vaccibody in June 2017. He holds a MD from Medical School, University of Copenhagen, an ECPM: a 2 year postgraduate educational program in pharmaceutical medicine, and a Master of Medical Business Strategies from Copenhagen Business School. Mads has since 1990 worked in drug development with medical aspects of clinical research regulatory affairs in varies large pharma and biotech companies. Mads started his career in Leo Pharma followed by Novo Nordisk A/S in DK, Novo Nordisk Pharmaceutical Inc., Princeton, USA; NatImmune A/S, Neurokey A/S, Hemofocus Aps., most recent

Research Interest

pharmaceutical medicine,